(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(pyridin-2-yl)propanoic acid, 95.0%, 10g

1-(2-Bromobenzyl)-1H-pyrazol-5-amine, 1g

5-Thiazolamine, 95.0%, 1g

3-[2-[2-[2-(3-methoxy-3-oxo-propoxy)ethoxy]ethoxy]ethoxy]propanoic acid, 250mg

3-Iodo-5-(trifluoromethoxy)-1H-indazole, 95%, 100mg

2-Hydroxy-4-methylthiazole-5-carboxylic acid, 95.0%, 25g

[2-(azepan-1-ylmethyl)phenyl]methanol, 95.0%, 10g

2-(1H-PYRAZOL-3-YL)ACETOHYDRAZIDE, 95.0%, 250mg

(4-(Dimethylamino)phenyl)boronic acid hydrochloride, 95%, 10g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(3,5-dimethylisoxazol-4-yl)phenyl)propanoic acid, 97%, 1g

Sample vials ROTILABO® with short thread ND9 silanised, Brown glass, with labelling space, 1.5 ml, 100 Piece(s)

Ethyl 2-oxo-2,3-dihydrooxazole-5-carboxylate, 95.0%, 5g

1-Bromo-2-n-butyloxy-5-chlorobenzene, 97.0%, 500mg